Literature DB >> 12039901

Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori.

Mayumi Tanaka, Emiko Isogai, Hiroshi Isogai, Shunji Hayashi, Kimiharu Hirose, Koichi Kimura, Toshiro Sugiyama, Kenichi Sato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12039901     DOI： 10.1093/jac/dkf055

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 2.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

3.  Helicobacter pylori eradication by sitafloxacin-lansoprazole combination and sitafloxacin pharmacokinetics in Mongolian gerbils and its in vitro activity and resistance development.

Authors:  Tatsuo Yamamoto; Tomomi Takano; Wataru Higuchi; Akihito Nishiyama; Ikue Taneike; Kumi Yoshida; Hiroko Kanda; Yuichiro Imamura
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

Review 4.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

5.  Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.

Authors:  Peipei Luo; Yanqiang Huang; Xudong Hang; Qian Tong; Liping Zeng; Jia Jia; Guoxin Zhang; Hongkai Bi
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

6.  Drug utilization of clarithromycin for gastrointestinal disease treatment.

Authors:  Quan Zhou; Ling-Ling Zhu; Xiao-Feng Yan; Wen-Sheng Pan; Su Zeng
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

7.  Dual therapy trial using esomeprazole and amoxicillin as third-line rescue therapy for Helicobacter pylori infection.

Authors:  Hyun Kyung Park; Dong Ho Lee; Seungchul Suh; Pyoung Ju Seo; Nayoung Kim; Sook-Hyang Jeong; Jin-Wook Kim; Jin-Hyeok Hwang; Young Soo Park; Sang Hyub Lee; Cheol Min Shin
Journal:  Clin Endosc       Date:  2011-09-30

8.  Rescue Therapy for Helicobacter pylori Infection 2012.

Authors:  Javier P Gisbert
Journal:  Gastroenterol Res Pract       Date:  2012-02-28       Impact factor: 2.260

9.  Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.

Authors:  Kang Hyun Choi; Woo Chul Chung; Kang-Moon Lee; Chang Nyol Paik; Eun Jung Kim; Bong Koo Kang; Ju Hyun Oak; Sung Hoon Jung
Journal:  J Korean Med Sci       Date:  2011-05-18       Impact factor: 2.153

10.  Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2009-02-28       Impact factor: 3.114
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.